Viromed Medical AG (Q11) — Financial Flexibility Index
Viromed Medical AG (Q11) has a Financial Flexibility Index of 0.14x as of September 2025. Free cash flow of €10.10 Million (operating CF €-10.12 Million minus capex €20.22 Million) represents 0% of total liabilities (€69.84 Million). Check Q11 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Viromed Medical AG Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for Viromed Medical AG across 4 annual periods. For the full cash flow conversion analysis, see Viromed Medical AG cash conversion from operations.
Annual Financial Flexibility Index for Viromed Medical AG (2021–2024)
Year-by-year free cash flow to debt coverage for Viromed Medical AG. Explore Q11 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.92x | €105.40 Million | €-6.03 Million | €54.82 Million | ▲ +938.3% |
| 2023 | -0.23x | €-9.85 Million | €-34.16 Million | €42.96 Million | ▲ +97.9% |
| 2022 | -11.00x | €-20.55 Million | €-20.87 Million | €1.87 Million | ▼ -197.1% |
| 2021 | -3.70x | €-10.41 Million | €-22.29 Million | €2.81 Million | — |